Organization
VivaVision Biotech
4 clinical trials
Clinical trial
A Phase 2, Double-masked, Randomized, Vehicle-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of VVN539 in Subjects With Primary Open Angle Glaucoma or Ocular HypertensionStatus: Completed, Estimated PCD: 2022-12-22
Clinical trial
A Phase 2, Double-masked, Randomized, Vehicle-controlled Study of VVN461 Ophthalmic Solution in Treating Post -Operative Ocular Inflammation in Subjects Undergoing Routine Unilateral Cataract SurgeryStatus: Recruiting, Estimated PCD: 2024-12-15
Clinical trial
A Phase 2a, Double-Masked, Randomized, Vehicle-controlled Trial Evaluating the Safety and Efficacy Activity of 1% and 5% VVN001 Compared to Vehicle in Subjects With Dry Eye DiseaseStatus: Completed, Estimated PCD: 2021-12-01
Clinical trial
A Phase 3, Randomized, Double-Masked, Vehicle-controlled, Multi-center Study Evaluating the Safety and Efficacy of 5% VVN001 in Chinese Subjects With Dry Eye DiseaseStatus: Not yet recruiting, Estimated PCD: 2026-03-01